ReP USP - Resultado da busca

Artigo de periodico
Influence of polymorphisms in IRS1, IRS2, MC3R, and MC4R on metabolic and inflammatory status and food intake in Brazilian adults: An exploratory pilot study (2023)
Fajardo, Cristina Moreno ; Cerda, Alvaro ; Bortolin, Raul Hernandes ; Oliveira, Raquel de; Stefani, Tamires Invencioni Moraes; Santos, Marina Aparecida dos; Braga, Aécio Assunção; Dorea, Egídio Lima; Bernik, Marcia Martins Silveira; Bastos, Gisele Medeiros; Sampaio, Marcelo Ferraz; Damasceno, Nágila Raquel Teixeira; Verlengia, Rozangela; Oliveira, Maria Rita Marques de; Hirata, Mario Hiroyuki ; Hirata, Rosario Dominguez Crespo
Fonte: Nutrition Research. Unidades: FCF, HU, FSP
Assuntos: POLIMORFISMO, OBESIDADE
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
FAJARDO, Cristina Moreno et al. Influence of polymorphisms in IRS1, IRS2, MC3R, and MC4R on metabolic and inflammatory status and food intake in Brazilian adults: An exploratory pilot study. Nutrition Research, v. 119, p. 21-32, 2023Tradução . . Disponível em: https://dx.doi.org/10.1016/j.nutres.2023.08.008. Acesso em: 05 out. 2024.
APA
Fajardo, C. M., Cerda, A., Bortolin, R. H., Oliveira, R. de, Stefani, T. I. M., Santos, M. A. dos, et al. (2023). Influence of polymorphisms in IRS1, IRS2, MC3R, and MC4R on metabolic and inflammatory status and food intake in Brazilian adults: An exploratory pilot study. Nutrition Research, 119, 21-32. doi:10.1016/j.nutres.2023.08.008
NLM
Fajardo CM, Cerda A, Bortolin RH, Oliveira R de, Stefani TIM, Santos MA dos, Braga AA, Dorea EL, Bernik MMS, Bastos GM, Sampaio MF, Damasceno NRT, Verlengia R, Oliveira MRM de, Hirata MH, Hirata RDC. Influence of polymorphisms in IRS1, IRS2, MC3R, and MC4R on metabolic and inflammatory status and food intake in Brazilian adults: An exploratory pilot study [Internet]. Nutrition Research. 2023 ; 119 21-32.[citado 2024 out. 05 ] Available from: https://dx.doi.org/10.1016/j.nutres.2023.08.008
Vancouver
Fajardo CM, Cerda A, Bortolin RH, Oliveira R de, Stefani TIM, Santos MA dos, Braga AA, Dorea EL, Bernik MMS, Bastos GM, Sampaio MF, Damasceno NRT, Verlengia R, Oliveira MRM de, Hirata MH, Hirata RDC. Influence of polymorphisms in IRS1, IRS2, MC3R, and MC4R on metabolic and inflammatory status and food intake in Brazilian adults: An exploratory pilot study [Internet]. Nutrition Research. 2023 ; 119 21-32.[citado 2024 out. 05 ] Available from: https://dx.doi.org/10.1016/j.nutres.2023.08.008
Artigo de periodico
Effect of statins on lipid metabolism-related microRNA expression in HepG2 cells (2021)
Cerda, Alvaro ; Bortolin, Raul Hernandes ; Manriquez, Victor; Salazar, Luis A ; Zambrano, Tomás ; Fajardo, Cristina Moreno ; Hirata, Mario Hiroyuki ; Hirata, Rosario Dominguez Crespo
Fonte: Pharmacological Reports. Unidade: FCF
Assuntos: MICRORNAS, LIPÍDEOS, MICRORNAS, EXPRESSÃO GÊNICA, ESTATINAS
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
CERDA, Alvaro et al. Effect of statins on lipid metabolism-related microRNA expression in HepG2 cells. Pharmacological Reports, v. 73, p. 1-13 art. 868–880, 2021Tradução . . Disponível em: https://doi.org/10.1007/s43440-021-00241-3. Acesso em: 05 out. 2024.
APA
Cerda, A., Bortolin, R. H., Manriquez, V., Salazar, L. A., Zambrano, T., Fajardo, C. M., et al. (2021). Effect of statins on lipid metabolism-related microRNA expression in HepG2 cells. Pharmacological Reports, 73, 1-13 art. 868–880. doi:10.1007/s43440-021-00241-3
NLM
Cerda A, Bortolin RH, Manriquez V, Salazar LA, Zambrano T, Fajardo CM, Hirata MH, Hirata RDC. Effect of statins on lipid metabolism-related microRNA expression in HepG2 cells [Internet]. Pharmacological Reports. 2021 ; 73 1-13 art. 868–880.[citado 2024 out. 05 ] Available from: https://doi.org/10.1007/s43440-021-00241-3
Vancouver
Cerda A, Bortolin RH, Manriquez V, Salazar LA, Zambrano T, Fajardo CM, Hirata MH, Hirata RDC. Effect of statins on lipid metabolism-related microRNA expression in HepG2 cells [Internet]. Pharmacological Reports. 2021 ; 73 1-13 art. 868–880.[citado 2024 out. 05 ] Available from: https://doi.org/10.1007/s43440-021-00241-3
Artigo de periodico
Peripheral blood mirome identified miR-155 as potential biomarker of MetS and cardiometabolic risk in obese patients (2021)
Cerda, Alvaro ; Amaral, Adonai Aralim; Oliveira, Raquel de; Moraes, Tamiris Invencioni; Braga, Aécio Assunção; Saldarriaga, Magda Elizabeth Graciano; Fajardo, Cristina Moreno ; Hirata, Thiago Dominguez Crespo ; Bonezi, Vivian; Salazar, Antony Brayan Campos ; Dórea, Egidio Lima; Bernik, Marcia Martins Silveira; Hirata, Mario Hiroyuki ; Hirata, Rosario Dominguez Crespo
Fonte: International of Journal Molecular Sciences. Unidades: FCF, HU
Assuntos: OBESIDADE, MICRORNAS
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
CERDA, Alvaro et al. Peripheral blood mirome identified miR-155 as potential biomarker of MetS and cardiometabolic risk in obese patients. International of Journal Molecular Sciences, v. 22, p. 1-14 art. 1468, 2021Tradução . . Disponível em: https://doi.org/10.3390/ijms22031468. Acesso em: 05 out. 2024.
APA
Cerda, A., Amaral, A. A., Oliveira, R. de, Moraes, T. I., Braga, A. A., Saldarriaga, M. E. G., et al. (2021). Peripheral blood mirome identified miR-155 as potential biomarker of MetS and cardiometabolic risk in obese patients. International of Journal Molecular Sciences, 22, 1-14 art. 1468. doi:10.3390/ijms22031468
NLM
Cerda A, Amaral AA, Oliveira R de, Moraes TI, Braga AA, Saldarriaga MEG, Fajardo CM, Hirata TDC, Bonezi V, Salazar ABC, Dórea EL, Bernik MMS, Hirata MH, Hirata RDC. Peripheral blood mirome identified miR-155 as potential biomarker of MetS and cardiometabolic risk in obese patients [Internet]. International of Journal Molecular Sciences. 2021 ; 22 1-14 art. 1468.[citado 2024 out. 05 ] Available from: https://doi.org/10.3390/ijms22031468
Vancouver
Cerda A, Amaral AA, Oliveira R de, Moraes TI, Braga AA, Saldarriaga MEG, Fajardo CM, Hirata TDC, Bonezi V, Salazar ABC, Dórea EL, Bernik MMS, Hirata MH, Hirata RDC. Peripheral blood mirome identified miR-155 as potential biomarker of MetS and cardiometabolic risk in obese patients [Internet]. International of Journal Molecular Sciences. 2021 ; 22 1-14 art. 1468.[citado 2024 out. 05 ] Available from: https://doi.org/10.3390/ijms22031468
Artigo de periodico
Genomics, epigenomics and pharmacogenomics of familial hypercholesterolemia (FHBGEP): a study protocol (2021)
Borges, Jéssica Bassani ; Oliveira, Victor Fernandes de ; Ferreira, Glaucio Monteiro ; Los, Bruna; Barbosa, Thais Kristini Almendros Afonso; Marçal, Elisangela da Silva Rodrigues; Hernandez, Carolina Dagli; Freitas, Renata Caroline Costa de ; Bortolin, Raul Hernandes ; Mori, Augusto Akira ; Hirata, Thiago Dominguez Crespo ; Nakaya, Helder Takashi Imoto ; Bastos, Gisele Medeiros ; Thurow, Helena Strelow ; Gonçalves, Rodrigo Marques; Araújo, Daniel Branco de; Zatz, Henry Paulo; Bertolami, Adriana; Faludi, André Arpad; Bertolami, Marcelo Chiara ; Sousa, Amanda Guerra de Moraes Rego ; França, Joao Italo Dias ; Jannes, Cinthia Elim; Pereira, Alexandre da Costa; Nakazone, Marcelo Arruda; Souza, Dorotéia Rossi Silva; Carmo, Tayanne Silva; Sampaio, Marcelo Ferraz; Gorjão, Renata ; Curi, Tania Cristina Pithon ; Moriel, Patricia; Silbiger, Vivian Nogueira ; Luchessi, André Ducati ; Araújo, Jéssica Nayara Góes de; Naslavsky, Michel ; Wang, Jaqueline Yu Ting; Kronenberger, Thales ; Cerda, Alvaro ; Wang, Hui Tzu Lin; Garofalo, Adriana Regina; Fajardo, Cristina Moreno ; Hirata, Rosario Dominguez Crespo ; Hirata, Mario Hiroyuki
Fonte: Research in Social and Administrative Pharmacy. Unidades: FCF, IDPC, FM, IB
Assuntos: GENÔMICA, HIPERCOLESTEROLEMIA, FARMACOGENÉTICA, EXONS, LINFÓCITOS, LINHAGEM CELULAR, MUTAGÊNESE, SEQUENCIAMENTO GENÉTICO
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
BORGES, Jéssica Bassani et al. Genomics, epigenomics and pharmacogenomics of familial hypercholesterolemia (FHBGEP): a study protocol. Research in Social and Administrative Pharmacy, v. 17, n. 7, p. 1347-1355, 2021Tradução . . Disponível em: https://doi.org/10.1016/j.sapharm.2020.10.007. Acesso em: 05 out. 2024.
APA
Borges, J. B., Oliveira, V. F. de, Ferreira, G. M., Los, B., Barbosa, T. K. A. A., Marçal, E. da S. R., et al. (2021). Genomics, epigenomics and pharmacogenomics of familial hypercholesterolemia (FHBGEP): a study protocol. Research in Social and Administrative Pharmacy, 17( 7), 1347-1355. doi:10.1016/j.sapharm.2020.10.007
NLM
Borges JB, Oliveira VF de, Ferreira GM, Los B, Barbosa TKAA, Marçal E da SR, Hernandez CD, Freitas RCC de, Bortolin RH, Mori AA, Hirata TDC, Nakaya HTI, Bastos GM, Thurow HS, Gonçalves RM, Araújo DB de, Zatz HP, Bertolami A, Faludi AA, Bertolami MC, Sousa AG de MR, França JID, Jannes CE, Pereira A da C, Nakazone MA, Souza DRS, Carmo TS, Sampaio MF, Gorjão R, Curi TCP, Moriel P, Silbiger VN, Luchessi AD, Araújo JNG de, Naslavsky M, Wang JYT, Kronenberger T, Cerda A, Wang HTL, Garofalo AR, Fajardo CM, Hirata RDC, Hirata MH. Genomics, epigenomics and pharmacogenomics of familial hypercholesterolemia (FHBGEP): a study protocol [Internet]. Research in Social and Administrative Pharmacy. 2021 ; 17( 7): 1347-1355.[citado 2024 out. 05 ] Available from: https://doi.org/10.1016/j.sapharm.2020.10.007
Vancouver
Borges JB, Oliveira VF de, Ferreira GM, Los B, Barbosa TKAA, Marçal E da SR, Hernandez CD, Freitas RCC de, Bortolin RH, Mori AA, Hirata TDC, Nakaya HTI, Bastos GM, Thurow HS, Gonçalves RM, Araújo DB de, Zatz HP, Bertolami A, Faludi AA, Bertolami MC, Sousa AG de MR, França JID, Jannes CE, Pereira A da C, Nakazone MA, Souza DRS, Carmo TS, Sampaio MF, Gorjão R, Curi TCP, Moriel P, Silbiger VN, Luchessi AD, Araújo JNG de, Naslavsky M, Wang JYT, Kronenberger T, Cerda A, Wang HTL, Garofalo AR, Fajardo CM, Hirata RDC, Hirata MH. Genomics, epigenomics and pharmacogenomics of familial hypercholesterolemia (FHBGEP): a study protocol [Internet]. Research in Social and Administrative Pharmacy. 2021 ; 17( 7): 1347-1355.[citado 2024 out. 05 ] Available from: https://doi.org/10.1016/j.sapharm.2020.10.007
Trabalho de evento-resumo
Influence of polymorphisms LEP c.-2548A>G and LEPR c.668A>G on metabolic alterations in a pediatric population of Southern Chile (2019)
Hirata, Rosario Dominguez Crespo ; Brito, R; Manriquez, Victor; Aguilar-Farias, N; Chandía-Poblete, D; Navarro, J; Fajardo, Cristina Moreno ; Hirata, Mario Hiroyuki ; Cerda, Alvaro
Fonte: Abstracts. Nome do evento: American Association for Clinical Chemistry/AACC. Unidade: FCF
Assuntos: POLIMORFISMO, OBESIDADE
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
HIRATA, Rosario Dominguez Crespo et al. Influence of polymorphisms LEP c.-2548A>G and LEPR c.668A>G on metabolic alterations in a pediatric population of Southern Chile. 2019, Anais.. Washington: AACC, 2019. . Acesso em: 05 out. 2024.
APA
Hirata, R. D. C., Brito, R., Manriquez, V., Aguilar-Farias, N., Chandía-Poblete, D., Navarro, J., et al. (2019). Influence of polymorphisms LEP c.-2548A>G and LEPR c.668A>G on metabolic alterations in a pediatric population of Southern Chile. In Abstracts. Washington: AACC.
NLM
Hirata RDC, Brito R, Manriquez V, Aguilar-Farias N, Chandía-Poblete D, Navarro J, Fajardo CM, Hirata MH, Cerda A. Influence of polymorphisms LEP c.-2548A>G and LEPR c.668A>G on metabolic alterations in a pediatric population of Southern Chile. Abstracts. 2019 ;[citado 2024 out. 05 ]
Vancouver
Hirata RDC, Brito R, Manriquez V, Aguilar-Farias N, Chandía-Poblete D, Navarro J, Fajardo CM, Hirata MH, Cerda A. Influence of polymorphisms LEP c.-2548A>G and LEPR c.668A>G on metabolic alterations in a pediatric population of Southern Chile. Abstracts. 2019 ;[citado 2024 out. 05 ]
Trabalho de evento-resumo
IRS2 rs1865434 variant is associated with adiposity and insulin resistance in brazilian subjects (2019)
Fajardo, Cristina Moreno ; Bortolin, Raul Hernandes ; Cerda, Alvaro; Freitas, Renata Caroline Costa de ; Oliveira, Raquel de; Moraes, Tamiris Invencioni; Malaquias, V. B; Hirata, Mario Hiroyuki ; Hirata, Rosario Dominguez Crespo
Fonte: Abstracts. Nome do evento: American Association for Clinical Chemistry/AACC. Unidade: FCF
Assuntos: ADIPOSIDADE, RESISTÊNCIA À INSULINA
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
FAJARDO, Cristina Moreno et al. IRS2 rs1865434 variant is associated with adiposity and insulin resistance in brazilian subjects. 2019, Anais.. Washington: AACC, 2019. . Acesso em: 05 out. 2024.
APA
Fajardo, C. M., Bortolin, R. H., Cerda, A., Freitas, R. C. C. de, Oliveira, R. de, Moraes, T. I., et al. (2019). IRS2 rs1865434 variant is associated with adiposity and insulin resistance in brazilian subjects. In Abstracts. Washington: AACC.
NLM
Fajardo CM, Bortolin RH, Cerda A, Freitas RCC de, Oliveira R de, Moraes TI, Malaquias VB, Hirata MH, Hirata RDC. IRS2 rs1865434 variant is associated with adiposity and insulin resistance in brazilian subjects. Abstracts. 2019 ;[citado 2024 out. 05 ]
Vancouver
Fajardo CM, Bortolin RH, Cerda A, Freitas RCC de, Oliveira R de, Moraes TI, Malaquias VB, Hirata MH, Hirata RDC. IRS2 rs1865434 variant is associated with adiposity and insulin resistance in brazilian subjects. Abstracts. 2019 ;[citado 2024 out. 05 ]
Artigo de periodico
Polymorphisms in genes involved in the Leptin-Melanocortin pathway are associated with Obesity-Related cardiometabolic alterations in a southern chilean population (2018)
Manriquez, Victor; Aviles, Jorge; Salazar, Luís; Saavedra, Nicolás; Seron, Pamela; Lanas, Fernando; Fajardo, Cristina Moreno ; Hirata, Mario Hiroyuki ; Hirata, Rosario Dominguez Crespo ; Cerda, Alvaro
Fonte: Molecular Diagnosis & Therapy. Unidade: FCF
Assuntos: POLIMORFISMO, LEPTINA, OBESIDADE
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
MANRIQUEZ, Victor et al. Polymorphisms in genes involved in the Leptin-Melanocortin pathway are associated with Obesity-Related cardiometabolic alterations in a southern chilean population. Molecular Diagnosis & Therapy, v. 22, n. 1, p. 101-113, 2018Tradução . . Disponível em: https://doi.org/10.1007/s40291-017-0306-8. Acesso em: 05 out. 2024.
APA
Manriquez, V., Aviles, J., Salazar, L., Saavedra, N., Seron, P., Lanas, F., et al. (2018). Polymorphisms in genes involved in the Leptin-Melanocortin pathway are associated with Obesity-Related cardiometabolic alterations in a southern chilean population. Molecular Diagnosis & Therapy, 22( 1), 101-113. doi:10.1007/s40291-017-0306-8
NLM
Manriquez V, Aviles J, Salazar L, Saavedra N, Seron P, Lanas F, Fajardo CM, Hirata MH, Hirata RDC, Cerda A. Polymorphisms in genes involved in the Leptin-Melanocortin pathway are associated with Obesity-Related cardiometabolic alterations in a southern chilean population [Internet]. Molecular Diagnosis & Therapy. 2018 ; 22( 1): 101-113.[citado 2024 out. 05 ] Available from: https://doi.org/10.1007/s40291-017-0306-8
Vancouver
Manriquez V, Aviles J, Salazar L, Saavedra N, Seron P, Lanas F, Fajardo CM, Hirata MH, Hirata RDC, Cerda A. Polymorphisms in genes involved in the Leptin-Melanocortin pathway are associated with Obesity-Related cardiometabolic alterations in a southern chilean population [Internet]. Molecular Diagnosis & Therapy. 2018 ; 22( 1): 101-113.[citado 2024 out. 05 ] Available from: https://doi.org/10.1007/s40291-017-0306-8
Artigo de periodico
Effects of clopidogrel on inflammatory cytokines and adhesion molecules in human endothelial cells: role of nitric oxide mediating pleiotropic effects (2017)
Cerda, Alvaro; Pavez, Mónica; Manriquez, Victor; Luchessi, André Ducati; Leal, Pamela; Benavente, Felipe; Fajardo, Cristina Moreno ; Salazar, Luís; Hirata, Mario Hiroyuki ; Hirata, Rosario Dominguez Crespo
Fonte: Cardiovascular Therapeutics. Unidade: FCF
Assuntos: ÓXIDO NÍTRICO, INFLAMAÇÃO, MOLÉCULAS DE ADESÃO CELULAR, CÉLULAS ENDOTELIAIS
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
CERDA, Alvaro et al. Effects of clopidogrel on inflammatory cytokines and adhesion molecules in human endothelial cells: role of nitric oxide mediating pleiotropic effects. Cardiovascular Therapeutics, v. 35, n. 4, p. 1-7 art. e12261, 2017Tradução . . Disponível em: https://doi.org/10.1111/1755-5922.12261. Acesso em: 05 out. 2024.
APA
Cerda, A., Pavez, M., Manriquez, V., Luchessi, A. D., Leal, P., Benavente, F., et al. (2017). Effects of clopidogrel on inflammatory cytokines and adhesion molecules in human endothelial cells: role of nitric oxide mediating pleiotropic effects. Cardiovascular Therapeutics, 35( 4), 1-7 art. e12261. doi:10.1111/1755-5922.12261
NLM
Cerda A, Pavez M, Manriquez V, Luchessi AD, Leal P, Benavente F, Fajardo CM, Salazar L, Hirata MH, Hirata RDC. Effects of clopidogrel on inflammatory cytokines and adhesion molecules in human endothelial cells: role of nitric oxide mediating pleiotropic effects [Internet]. Cardiovascular Therapeutics. 2017 ; 35( 4): 1-7 art. e12261.[citado 2024 out. 05 ] Available from: https://doi.org/10.1111/1755-5922.12261
Vancouver
Cerda A, Pavez M, Manriquez V, Luchessi AD, Leal P, Benavente F, Fajardo CM, Salazar L, Hirata MH, Hirata RDC. Effects of clopidogrel on inflammatory cytokines and adhesion molecules in human endothelial cells: role of nitric oxide mediating pleiotropic effects [Internet]. Cardiovascular Therapeutics. 2017 ; 35( 4): 1-7 art. e12261.[citado 2024 out. 05 ] Available from: https://doi.org/10.1111/1755-5922.12261
Trabalho de evento-resumo
Análisis de la expresión global de microRNAs identifica el MIR-155 como biomarcador y potencial albo terapéutico para el riesgo cardiometabólico entre individuos obesos (2017)
Maureira, Alvaro Danilo Cerda; Amaral, Adonai; Oliveira, Raquel de; Braga, Aécio Assunção; Graciano, Elizabeth; Fajardo, Cristina Moreno ; Dórea, Egídio Lima; Bernik, Marcia Martins Silveira; Hirata, Thiago Dominguez Crespo; Hirata, Mario Hiroyuki ; Hirata, Rosario Dominguez Crespo
Fonte: Resumos. Nome do evento: Congreso Chileno de Endocrinologia y Diabetes. Unidades: FCF, HU
Assuntos: BIOMARCADORES, MICRORNAS
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
MAUREIRA, Alvaro Danilo Cerda et al. Análisis de la expresión global de microRNAs identifica el MIR-155 como biomarcador y potencial albo terapéutico para el riesgo cardiometabólico entre individuos obesos. 2017, Anais.. Chile: Sociedad Chilena de Endocrinologia y Diabetes, 2017. . Acesso em: 05 out. 2024.
APA
Maureira, A. D. C., Amaral, A., Oliveira, R. de, Braga, A. A., Graciano, E., Fajardo, C. M., et al. (2017). Análisis de la expresión global de microRNAs identifica el MIR-155 como biomarcador y potencial albo terapéutico para el riesgo cardiometabólico entre individuos obesos. In Resumos. Chile: Sociedad Chilena de Endocrinologia y Diabetes.
NLM
Maureira ADC, Amaral A, Oliveira R de, Braga AA, Graciano E, Fajardo CM, Dórea EL, Bernik MMS, Hirata TDC, Hirata MH, Hirata RDC. Análisis de la expresión global de microRNAs identifica el MIR-155 como biomarcador y potencial albo terapéutico para el riesgo cardiometabólico entre individuos obesos. Resumos. 2017 ;[citado 2024 out. 05 ]
Vancouver
Maureira ADC, Amaral A, Oliveira R de, Braga AA, Graciano E, Fajardo CM, Dórea EL, Bernik MMS, Hirata TDC, Hirata MH, Hirata RDC. Análisis de la expresión global de microRNAs identifica el MIR-155 como biomarcador y potencial albo terapéutico para el riesgo cardiometabólico entre individuos obesos. Resumos. 2017 ;[citado 2024 out. 05 ]
Artigo de periodico
Effects of short-term add-on ezetimibe to statin treatment on expression of adipokines and inflammatory markers in diabetic and dyslipidemic patients (2017)
Guimarães, Elizandra Silva; Cerda, Alvaro; Dórea, Egídio Lima; Bernik, Marcia Martins Silveira; Gusukuma, Maria Cecília; Pinto, Gelba Almeida; Fajardo, Cristina Moreno ; Hirata, Mario Hiroyuki ; Hirata, Rosario Dominguez Crespo
Fonte: Cardiovascular Therapeutics. Unidades: HU, FCF
Assuntos: DISLIPIDEMIAS, HIPERCOLESTEROLEMIA
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
GUIMARÃES, Elizandra Silva et al. Effects of short-term add-on ezetimibe to statin treatment on expression of adipokines and inflammatory markers in diabetic and dyslipidemic patients. Cardiovascular Therapeutics, v. 35, n. 6, p. art. e12307 1-8, 2017Tradução . . Disponível em: https://doi.org/10.1111/1755-5922.12307. Acesso em: 05 out. 2024.
APA
Guimarães, E. S., Cerda, A., Dórea, E. L., Bernik, M. M. S., Gusukuma, M. C., Pinto, G. A., et al. (2017). Effects of short-term add-on ezetimibe to statin treatment on expression of adipokines and inflammatory markers in diabetic and dyslipidemic patients. Cardiovascular Therapeutics, 35( 6), art. e12307 1-8. doi:10.1111/1755-5922.12307
NLM
Guimarães ES, Cerda A, Dórea EL, Bernik MMS, Gusukuma MC, Pinto GA, Fajardo CM, Hirata MH, Hirata RDC. Effects of short-term add-on ezetimibe to statin treatment on expression of adipokines and inflammatory markers in diabetic and dyslipidemic patients [Internet]. Cardiovascular Therapeutics. 2017 ; 35( 6): art. e12307 1-8.[citado 2024 out. 05 ] Available from: https://doi.org/10.1111/1755-5922.12307
Vancouver
Guimarães ES, Cerda A, Dórea EL, Bernik MMS, Gusukuma MC, Pinto GA, Fajardo CM, Hirata MH, Hirata RDC. Effects of short-term add-on ezetimibe to statin treatment on expression of adipokines and inflammatory markers in diabetic and dyslipidemic patients [Internet]. Cardiovascular Therapeutics. 2017 ; 35( 6): art. e12307 1-8.[citado 2024 out. 05 ] Available from: https://doi.org/10.1111/1755-5922.12307

Unidades USP

ReP

Filtros

Unidades USP

Autores

Autores USP

Assuntos

Título da fonte

Grupo de pesquisa

Agência de fomento

Afiliação dos autores externos não normalizada